New Mexico has reached a $2.25 million settlement with Mylan Inc., the pharmaceutical company behind EpiPen Auto-Injectors, which are used as emergency treatment for severe allergic reactions. The ...

New Mexico Attorney General Raúl Torrez said the state reached a $2.25 million settlement over claims a pharmaceutical ...

(RTTNews) - Viatris (VTRS) said Wednesday that the U.S. District Court for the District of Kansas ruled, in substantial part, in Mylan's favor on the company's summary judgment motion in the class ...

New Mexico Attorney General Raúl Torrez announced that the State of New Mexico has reached a $2.25 million settlement with ...

June 29 (Reuters) - Drugmaker Sanofi SASY.PA asked a U.S. judge on Wednesday to curb Mylan's bid to recover litigation costs in an antitrust lawsuit, calling the rival pharmaceutical company's court ...

NEW YORK (CBSNewYork) — Meridian Medical Technologies, makers of Mylan's EpiPen Auto-Injector, have issued a voluntary recall of its EpiPen and EpiPen Jr. injectors. "The potential defect could make ...

While EpiPen prescriptions are still increasing, Mylan’s share of the epinephrine auto-injector market fell for the first time in three years, according to research from athenahealth. The analysis is ...

While numerous companies attempted to set foot in the epinephrine auto-injection market, none were able to significantly impact Canonsburg, Pa.-based Mylan’s control of the market. This dominance ...

In addition to a $2.25 million monetary settlement, the company will donate thousands of EpiPens to the state annually for ...